Pages that link to "Q39591919"
Jump to navigation
Jump to search
The following pages link to Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediate (Q39591919):
Displaying 50 items.
- Optimization of naked DNA delivery for interferon subtype immunotherapy in cytomegalovirus infection (Q24801716) (← links)
- Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1? (Q26865388) (← links)
- Lower levels of gamma interferon expressed by a pseudotyped single-cycle simian immunodeficiency virus enhance immunogenicity in rats. (Q30373857) (← links)
- T-cell immune responses against Env from CRF12_BF and subtype B HIV-1 show high clade-specificity that can be overridden by multiclade immunizations (Q33833624) (← links)
- The influence of delivery vectors on HIV vaccine efficacy (Q34077543) (← links)
- Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection (Q34131388) (← links)
- A novel, live-attenuated vesicular stomatitis virus vector displaying conformationally intact, functional HIV-1 envelope trimers that elicits potent cellular and humoral responses in mice (Q34172295) (← links)
- Novel mucosal DNA-MVA HIV vaccination in which DNA-IL-12 plus cholera toxin B subunit (CTB) cooperates to enhance cellular systemic and mucosal genital tract immunity (Q34172564) (← links)
- Genetic adjuvants for DNA vaccines (Q34189226) (← links)
- Role of free radicals in viral pathogenesis and mutation (Q34191797) (← links)
- IL-12 and GM-CSF in DNA/MVA immunizations against HIV-1 CRF12_BF Nef induced T-cell responses with an enhanced magnitude, breadth and quality (Q34289072) (← links)
- Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV) infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques (Q34331118) (← links)
- Nitric oxide and T helper cell immunity (Q34342640) (← links)
- Rational development of prophylactic HIV vaccines based on structural and regulatory proteins (Q34416398) (← links)
- Nucleic acid vaccines: tasks and tactics. (Q34510525) (← links)
- Subsets of memory cytotoxic T lymphocytes elicited by vaccination influence the efficiency of secondary expansion in vivo (Q34554756) (← links)
- Immune therapy: non-highly active antiretroviral therapy management of human immunodeficiency virus-infected patients (Q34631665) (← links)
- Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins. (Q34976881) (← links)
- Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma. (Q35600772) (← links)
- Pseudotyped single-cycle simian immunodeficiency viruses expressing gamma interferon augment T-cell priming responses in vitro (Q35784773) (← links)
- Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants (Q35826378) (← links)
- Cytokine therapies in HIV-1 infection: present and future (Q35917144) (← links)
- Combined IL-12 Plasmid and Recombinant SjGST Enhance the Protective and Anti-pathology Effect of SjGST DNA Vaccine Against Schistosoma japonicum. (Q35927470) (← links)
- The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses (Q35951849) (← links)
- Fighting cancer with vaccinia virus: teaching new tricks to an old dog. (Q36018992) (← links)
- The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responses (Q36256348) (← links)
- Virus-like particles: designing an effective AIDS vaccine (Q36602273) (← links)
- IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques (Q36694836) (← links)
- The potential of topical DNA vaccines adjuvanted by cytokines (Q36960508) (← links)
- Enhancing poxvirus vectors vaccine immunogenicity. (Q36978452) (← links)
- Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella (Q37078471) (← links)
- Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity (Q37590335) (← links)
- Golgi phosphoprotein 2 in physiology and in diseases (Q38041690) (← links)
- Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant (Q39684976) (← links)
- Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. (Q39741884) (← links)
- Mucosal HIV-1 pox virus prime-boost immunization induces high-avidity CD8+ T cells with regime-dependent cytokine/granzyme B profiles (Q40245279) (← links)
- Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2. (Q40361792) (← links)
- A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection (Q40545484) (← links)
- Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid (Q40663773) (← links)
- Interleukin-12 therapy reduces the number of immune cells and pathology in lungs of mice infected with Mycobacterium tuberculosis (Q40764004) (← links)
- Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma (Q41679793) (← links)
- DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA. (Q41995910) (← links)
- SIV antigen-specific effects on immune responses induced by vaccination with DNA electroporation and plasmid IL-12. (Q42276031) (← links)
- Viral reservoir is suppressed but not eliminated by CD8 vaccine specific lymphocytes (Q43508253) (← links)
- A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques (Q43602552) (← links)
- Protective immune response against cutaneous leishmaniasis by prime/booster immunization regimens with vaccinia virus recombinants expressing Leishmania infantum p36/LACK and IL-12 in combination with purified p36. (Q43698528) (← links)
- IL-12/GM-CSF Coadministration in an SIV DNA Prime/Protein Boost Protocol Enhances Gag-Specific T Cells But Not Virus-Specific Neutralizing Antibodies in Rhesus Macaques (Q43892595) (← links)
- Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma (Q44340720) (← links)
- A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens (Q44825298) (← links)
- Interleukin-12 as a genetic adjuvant enhances hepatitis C virus NS3 DNA vaccine immunogenicity. (Q45351044) (← links)